Andropause: an androgen deficiency state in the ageing male

Bibliography

• MATSUMOTO AM: Andropause: clinical implications of the decline in serum testosterone levels with aging in men. Cerentel Med. Sci. (2002) 57A(2):M76–M99.
   Google Scholar
• FRONTERA WR, HUGHES VA, LUTZ KJ, EVANS WJ: A cross-sectional study of muscle strength and mass in 45-78 year old men and women.Appl Physiel (1991) 71:644–650.
   PubMed Web of Science ®Google Scholar
• GALLAGHER D, VISSER M, DEMEERSMAN RE et al.: Appendicular skeletal muscle mass: effects of age, gender and ethnicity. Appl. Physiel (1997) 83:229–239.
   PubMed Web of Science ®Google Scholar
• LARSSON L, RAMAMURTHY B: Aging-related changes in skeletal muscle. Mechanisms and interventions. Drugs Aging (2000) 17(4):303–316.
   PubMed Web of Science ®Google Scholar
• HUGHES VA, FRONTERA WR, WOOD M et al.: Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity and health. Cerentel Biel Sci. (2001) 56A:B209–B217.
   Google Scholar
• JOHANNES CB, ARAUJO AB, FELDMAN HA, DERBY CA, KLEINMAN KP, MCKINLAY JB: Incidence of erectile dysfunction in men 40-60 years old: longitudinal results from the Massachusetts male aging study.Um]. (2000) 163:460–463.
   Web of Science ®Google Scholar
• ROWLAND DL, GREENLEAF WJ, DORFMAN LJ, DAVIDSON JM: Aging and sexual function in men. Arch. Sex. Behav. (1993) 22:545–557.
   PubMed Web of Science ®Google Scholar
• BOSWORTH HB, SCHAIE KW, WILLIS SL: Cognitive and sociodemographic risk factors for mortality in the Seattle Longitudinal Study. Cerentel Psych. Sci. (1999) 54B:P273–P282.
   Google Scholar
• SPRATT DI, COX P, ORAY J, MOLONEY J, BIGOS T: Reproductive axis suppression in acute illness is related to disease severity. Clin. Endocrine]. Metab. (1993) 76:1548–1554.
   PubMed Web of Science ®Google Scholar
• SPARROW D, BOSSE R, ROWE JW: The influence of age, alcohol consumption and body fluid on gonodal function in men. Gin. Endocrine]. Metab. (1980) 51:508–512.
   PubMed Web of Science ®Google Scholar
• SWERDLOFF RS, WANG C: Androgens and aging in men. Exp. Cerentel (1993) 28:435–446.
   PubMed Web of Science ®Google Scholar
• VERMEULEN A: Androgens in the agingmale. Clin. Endrecrinel Metab. (1991) 73:221–224.
   PubMed Web of Science ®Google Scholar
• MANNI A, PARDRIDGE WM, CEFALU W et al.: Bioavailability of albumin-bound testosterone. J. Clin. Endocrine]. Metab. (1985) 61:705–710.
   PubMed Web of Science ®Google Scholar
• •A seminal study documenting in vitro and in vivo the relative bioavailability of absolute free testosterone and albumin-bound testosterone into the brain as a percent of total circulating testosterone and the unavailability of testosterone bound to sex hormone binding globulin.
   Google Scholar
• VERMEULEN A, VERDONCK L, KAUFMAN JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. Clin. Endocrine]. Metab. (1999) 84:3666–3672.
   PubMed Web of Science ®Google Scholar
• HARMAN SM, METTER EJ, TOBIN JD,PEARSON J, BLACKMAN MR: Longitudinal effects of aging in serum totaland free testosterone levels in healthy men.Baltimore longitudinal study of aging. Clin. Endocrine]. Metab. (2001) 86:724–731.
   PubMed Web of Science ®Google Scholar
• •Examined the issue of ageing versus chronic illness on changes in total and free testosterone in a large population-based longitudinal study. The study was carried out over a 30-year period and showed a significant, independent, age-invariant, longitudinal effect of age on total and free testosterone. The study revealed a higher incidence of hypogonadal testosterone levels with age (20% over 60 years; 30% over 70 years and 50% over 80 years).
   Google Scholar
• GRAY A, FELDMAN HA,MCKINLAY JB, LONGCOPE C: Age, disease and changing sex hormone levels in middle-aged men: results of the massachusetts male aging study. Clin. Endocrine]. Metab. (1991) 73:1016–1025.
   PubMed Web of Science ®Google Scholar
• •First large scale epidemiological study examining in detail hormonal changes in men of age 39–70. Study showed that free and bioavailable testosterone declines by 1.2%/year over this period.
   Google Scholar
• KAUFMAN JM, VERMEULEN A: Declining gonodal function in ederly men. Bailieres Clin. Endocrine]. Metab. (1997) 11:289–309.
   PubMed Web of Science ®Google Scholar
• MALARKEY WB, HALL JC, RICE RR et al: The influence of age on endocrine responses to ultraendurance stress. Cerentel (1993) 48(4):M134–M139.
   Google Scholar
• GRIFFIN JE, WILSON JD: Disorders of the testes and the male reproductive tract. In: Williams Textbook of Endocrinology 9th edn. JD Wilson, DW Foster, HM Kronenberg, PR Larsen (Eds). WB Saunders (1998):Chapter 16.
   Google Scholar
• BARTSCH W: Interrelationships betweenSHBG and testosterone, 5a DHT and 17-0 estradiol in blood of normal men. Maturitas (1980) 2:109–118.
   PubMed Web of Science ®Google Scholar
• SODERGARD R, BACKSTROM T, SHANBHAG V, CARSTENSEN H: Calculation of free and bound fractions of testosterone and 17-0 estradiol to human plasma proteins at body temperature. J. Steroid Biochem. (1982) 16(6):801–810.
   PubMedGoogle Scholar
• NEAVES WB, JOHNSON L,PORTER JC, PARKER CR, PETTY CS: Leydig cell numbers, daily sperm production and serum gonadotropin levels in aging men. I. Clin. Endocrinol Metab. (1984) 59:756–763.
   PubMed Web of Science ®Google Scholar
• JOHANNES CB, ARAUJO AB, FELDMAN HA, DERBY CA, KLEINMAN KP, MCKINLAY JB: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study." Urol. (2000) 163:460–463.
   PubMed Web of Science ®Google Scholar
• ROWLAND DI, GREENLEAF WJ, DORFMAN LJ, DAVIDSON JM: Aging and sexual function in men. Arch. Sex. Behav. (1993) 22:545–557.
   PubMed Web of Science ®Google Scholar
• HAJJAR RR, KAISER FE, MORLEY JE:Outcomes of long-term testosterone replacement in older hypogonodal males: a retrospective analysis. " Clin. Endocrinol Metab. (1997) 82:3793–3796.
   PubMed Web of Science ®Google Scholar
• TENOVER JS, MATSUMOTO AM, CLIFTON DK, BREMNER WJ: Age related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men. Gerontol Med. Sci. (1988) 43:M163–M169.
   Google Scholar
• PINCUS SM, MULLIGAN T, IRANMANESH A, GHEORGHIU S, GODSCHALK M, VELDHUIS JD: Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc. Natl. Acad. Sci. USA (1996) 93:14100–14105.
   PubMed Web of Science ®Google Scholar
• VERMEULEN A, DESLYPERE JP, KAUFMAN JM: Influence of anti-opioids on luteinizing hormone pulsalility in aging men. I Clin. Endocrinol Metab. (1989) 68:68–72.
   PubMed Web of Science ®Google Scholar
• MIKUMA N, KUMAMOTO Y, MARUTA H, NITTA T: The role of the hypothalamic opioidergic system in the control of gonadotropin secretion in elderly men. Audrologia (1994) 26:39–45.
   PubMed Web of Science ®Google Scholar
• BAULIEU EE, THOMAS G, LEGRAIN Set al.: Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc. Natl. Acad. Sri. USA (2000) 97:4279–4284.
   Google Scholar
• ORENTREICH N, BRIND JL, VOGELMAN JH, ANDRES R, BALDWIN H: Long termlongitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. I Gin. Endocrinol Metab. (1992) 75:1002–1004.
   PubMed Web of Science ®Google Scholar
• ORENTREICH N, BRIND JL, RIZER RL, VOGELMAN JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Clin. Endocrinol Metab. (1984) 59:551–555.
   Google Scholar
• ALESCI S, KOCH CA, BORNSTEIN SR, PACAK K: Adrenal androgen regulation and andrenopause. Endocr. Regal (2001) 35(2):95–100.
   PubMedGoogle Scholar
• ROLF C, NIESCHLAG E: Potential adverse effects of long-term testosterone therapy. Baillieres Clin. Endocrinol Metab. (1988) 12:521–534.
   Google Scholar
• BAKHSHI V, ELLIOTT M, GENTILI A, GODSCHALK M, MULLIGAN T: Testosterone improves rehabilitatin outcomes in ill older men.J. Ain. Geriatric Soc. (2000) 48:550–553.
   PubMed Web of Science ®Google Scholar
• BENKERT 0, WITT W, ADAM W, LEITZ A: Effects of testosterone undecanoate on sexual potency and the hypothalamic pituitary gonadal axis of impotent males. Arch. Sex. Behav. (1979) 8:471–479.
   PubMed Web of Science ®Google Scholar
• CHERRIER MM, ASTHANA S, PLYMATE S et al.: Testosterone Supplementation improves spatial and verbal memory in healthy older men. Neurology (2001) 57:80–88.
   PubMed Web of Science ®Google Scholar
• KENNY AM, PRESTWOOD KM, GRUMAN CA, MARCELLO KM, RAISZ LG: Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.' Gerontol Med. Sci. (2001) 56A:M266–M272.
   Google Scholar
• SCHIAVI RC, WHITE D, MANDELI J, LEVINE AC: Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Arch. Sex. Behav. (1997) 26:231–241.
   PubMed Web of Science ®Google Scholar
• SIH R, MORLEY JE, KAISER FE, PERRY HM, PATRICK P, ROSS C:Testosterone replacement in older hypogonadal men: a 12 month randomized clinical trial. I. Clin. Endocrinol. Metab. (1997) 82:1661–1667.
   PubMed Web of Science ®Google Scholar
• •First published study on the beneficial effects of long term testosterone treatment in older men (> 50 years) with low bioavailable testosterone levels. Hormone replacement therapy increased grip strength and haemoglobin levels and had no significant effects on serum PSA levels or prostate gland size as determined by digital rectal examination.
   Google Scholar
• SNYDER PH, PEACHEY H, HANNOUSH P et al: Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. I Clin. Endocrinol Metab. (1999) 84:2647–2653.
   PubMed Web of Science ®Google Scholar
• DRINKA PJ, JOCHEN AL,CUISINIER M, BLOOM R, RUDMAN I, RUDMAN D: Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. " Am. Geriatric Soc. (1995) 43:899–901.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER BK, PICKETT CK, ZWILLICH CW et al.: Influence of testosterone on breathing during sleep. Appl. Physic] (1986) 61:618–623.
   PubMed Web of Science ®Google Scholar
• GANN PH, HENNEKENS CH, MA J, LONGCOPE C, STAMPFER MJ: Prospective study of sex hormone levels and risk of prostate cancer. J. Natl. Cancer Inst. (1996) 88:1118–1126.
   PubMed Web of Science ®Google Scholar
• SNYDER PH, LAWRENCE DA: Treatment of male hypogonadism with testosterone enanthate. Clin.Endocrinol. Metab. (1980) 51:1335–1339.
   Google Scholar
• AHMED SR, BOUCHER AE, MANNI A, SANTEN RJ, DEMERS LM: Transdermal testosterone therapy in the treatment of male hypogonadism. Clin. Endocrinol Metab. (1990) 66(3):546–551.
   Google Scholar
• MCCLELLAN KJ, GOA KU: Transdermal testosterone. Drugs (1998) 55:253–258.
   PubMed Web of Science ®Google Scholar
• WANG C, SWERDLOFF R, IRANMANESH A et al.: Transdermal testosterone gel improves sexual function, mood, muscle strength and body composition parameters in hypogonadal men. I Clin. Endocrinol Metab. (2000) 85:2839–2853.
   PubMed Web of Science ®Google Scholar
• •Large, randomised, multi-centre clinical trial of a well characterised population of hypogonadal men evaluating the efficacy of a testosterone gel preparation on sexual function and other measures of androgen
   Google Scholar